Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss

Rune Rasmussen, Magnus Claesson, Sven-Eric Stangerup, Henrik Roed, Ib Jarle Christensen, Per Caye Thomasen, Marianne Juhler

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    35 Citationer (Scopus)

    Abstract

    To evaluate long-term tumor control and hearing preservation rates in patients with vestibular schwannoma treated with fractionated stereotactic radiotherapy (FSRT), comparing hearing preservation rates to an untreated control group. The relationship between radiation dose to the cochlea and hearing preservation was also investigated.
    OriginalsprogEngelsk
    TidsskriftInternational Journal of Radiation Oncology, Biology, Physics
    Vol/bind83
    Udgave nummer5
    Sider (fra-til)e607-11
    ISSN0360-3016
    DOI
    StatusUdgivet - 2012

    Citationsformater